Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel

Fig. 2

Perceived impact of INQoL domains on patient QoL. Key: INQoL, Individualized Neuromuscular Quality of Life; QoL, quality of life. Note: Higher scores indicate higher perceived impact on patient QoL. Experts were asked to rank domains of INQoL based on their perceived impact on QoL (from 1 – highest impact, to 10 – lowest impact). The overall score for each domain was derived by calculating the mean of all expert responses (assigning the most impactful domain a 10 and the least impactful domain a 1)

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us